News on Inovio Biomedical from BioPortfolio.com http://www.BioPortfolio.com Consolidated Inovio Biomedical news from BioPortfolio.com Wed, 10 Feb 2010 05:49:52 GMT en News and FDA Updates for IMS (NYSE:RX), Inovio (NYSE:INO), Heska (Nasdaq:HSKA)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035378&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035378&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035378&HITNO=0&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035378&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218463%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Inovio shows postive results in ongoing cancer vaccine studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034028&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034028&THISHREF=http://c.moreover.com/click/here.pl%3fz2535565498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034028&HITNO=1&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034028&THISHREF=http://c.moreover.com/click/here.pl%3fz2535565498%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Daily Transcript: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028702&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028702&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028702&HITNO=2&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028702&THISHREF=http://c.moreover.com/click/here.pl%3fz2532826529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: ::: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Thttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031489&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031489&THISHREF=http://c.moreover.com/click/here.pl%3fz2534231024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031489&HITNO=3&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031489&THISHREF=http://c.moreover.com/click/here.pl%3fz2534231024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029617&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029617&THISHREF=http://c.moreover.com/click/here.pl%3fz2533210053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029617&HITNO=4&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029617&THISHREF=http://c.moreover.com/click/here.pl%3fz2533210053%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028938&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028938&THISHREF=http://c.moreover.com/click/here.pl%3fz2532918607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028938&HITNO=5&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028938&THISHREF=http://c.moreover.com/click/here.pl%3fz2532918607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response inhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028882&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028882&THISHREF=http://c.moreover.com/click/here.pl%3fz2532885436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028882&HITNO=6&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028882&THISHREF=http://c.moreover.com/click/here.pl%3fz2532885436%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028952&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028952&THISHREF=http://c.moreover.com/click/here.pl%3fz2532926828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028952&HITNO=7&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028952&THISHREF=http://c.moreover.com/click/here.pl%3fz2532926828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028685&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028685&THISHREF=http://c.moreover.com/click/here.pl%3fz2532819142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028685&HITNO=8&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028685&THISHREF=http://c.moreover.com/click/here.pl%3fz2532819142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028623&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028623&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028623&HITNO=9&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028623&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028548&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028548&THISHREF=http://c.moreover.com/click/here.pl%3fz2532760487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028548&HITNO=10&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028548&THISHREF=http://c.moreover.com/click/here.pl%3fz2532760487%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028566&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028566&THISHREF=http://c.moreover.com/click/here.pl%3fz2532767764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028566&HITNO=11&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028566&THISHREF=http://c.moreover.com/click/here.pl%3fz2532767764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Inovio's Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029585&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029585&THISHREF=http://c.moreover.com/click/here.pl%3fz2533197559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029585&HITNO=12&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029585&THISHREF=http://c.moreover.com/click/here.pl%3fz2533197559%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Inovio's Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029403&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029403&THISHREF=http://c.moreover.com/click/here.pl%3fz2533127540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029403&HITNO=13&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029403&THISHREF=http://c.moreover.com/click/here.pl%3fz2533127540%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028895&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028895&THISHREF=http://c.moreover.com/click/here.pl%3fz2532888330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028895&HITNO=14&MSIZE=95&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inovio%20Biomedical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028895&THISHREF=http://c.moreover.com/click/here.pl%3fz2532888330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: